244 related articles for article (PubMed ID: 30809474)
1. Th lymphocyte subsets in patients with Vogt-Koyanagi-Harada disease.
Liang L; Peng XY; Wang H
Int J Ophthalmol; 2019; 12(2):207-211. PubMed ID: 30809474
[TBL] [Abstract][Full Text] [Related]
2. Diminished frequency and function of CD4+CD25high regulatory T cells associated with active uveitis in Vogt-Koyanagi-Harada syndrome.
Chen L; Yang P; Zhou H; He H; Ren X; Chi W; Wang L; Kijlstra A
Invest Ophthalmol Vis Sci; 2008 Aug; 49(8):3475-82. PubMed ID: 18421089
[TBL] [Abstract][Full Text] [Related]
3. Th1/Th2/Th17/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: Correlation with disease activity.
Talaat RM; Mohamed SF; Bassyouni IH; Raouf AA
Cytokine; 2015 Apr; 72(2):146-53. PubMed ID: 25647269
[TBL] [Abstract][Full Text] [Related]
4. Increased IL-7 expression in Vogt-Koyanagi-Harada disease.
Yang Y; Xiao X; Li F; Du L; Kijlstra A; Yang P
Invest Ophthalmol Vis Sci; 2012 Feb; 53(2):1012-7. PubMed ID: 22247488
[TBL] [Abstract][Full Text] [Related]
5. IL-10 and TGF-beta immunoregulatory cytokines rather than natural regulatory T cells are associated with the resolution phase of Vogt-Koyanagi-Harada (VKH) syndrome.
Commodaro AG; Peron JP; Genre J; Arslanian C; Sanches L; Muccioli C; Rizzo LV; Belfort R
Scand J Immunol; 2010 Jul; 72(1):31-7. PubMed ID: 20591073
[TBL] [Abstract][Full Text] [Related]
6. The role of interleukin-1 receptor-associated kinases in Vogt-Koyanagi-Harada disease.
Sun M; Yang P; Du L; Yang Y; Ye J
PLoS One; 2014; 9(4):e93214. PubMed ID: 24690905
[TBL] [Abstract][Full Text] [Related]
7. Increased serum level of interleukin-33 in Vogt-Koyanagi-Harada correlates with disease activity.
Qian Y; Yu R; Zhao C; Gao F; Zhang M
Clin Immunol; 2021 Oct; 231():108846. PubMed ID: 34478883
[TBL] [Abstract][Full Text] [Related]
8. Disabled-2 (DAB2) Overexpression Inhibits Monocyte-Derived Dendritic Cells' Function in Vogt-Koyanagi-Harada Disease.
Yi S; Chang R; Hu J; Qiu Y; Wang Q; Cao Q; Yuan G; Su G; Zhou C; Wang Y; Kijlstra A; Yang P
Invest Ophthalmol Vis Sci; 2018 Sep; 59(11):4662-4669. PubMed ID: 30267088
[TBL] [Abstract][Full Text] [Related]
9. Classification of Peripheral Blood Leukocyte Phenotypes and Serum Cytokines in Vogt-Koyanagi-Harada Disease before and after Glucocorticoid Therapy.
Sato T; Taniguchi N; Nishio Y; Ito M; Takeuchi M
J Clin Med; 2023 Dec; 12(24):. PubMed ID: 38137811
[TBL] [Abstract][Full Text] [Related]
10. Decreased expression of A20 is associated with ocular Behcet's disease (BD) but not with Vogt-Koyanagi-Harada (VKH) disease.
He Y; Wang C; Su G; Deng B; Ye Z; Huang Y; Yuan G; Aize K; Li H; Yang P
Br J Ophthalmol; 2018 Aug; 102(8):1167-1172. PubMed ID: 29699987
[TBL] [Abstract][Full Text] [Related]
11. Decreased IL-27 expression in association with an increased Th17 response in Vogt-Koyanagi-Harada disease.
Wang C; Tian Y; Lei B; Xiao X; Ye Z; Li F; Kijlstra A; Yang P
Invest Ophthalmol Vis Sci; 2012 Jul; 53(8):4668-75. PubMed ID: 22669715
[TBL] [Abstract][Full Text] [Related]
12. Shenghua Decoction reduces uterine bleeding and regulates T-cell paradigm in human deciduas of RU486 medical abortion.
Li X; Zhang M; Wang B; Li Y; Wang L; Zhao X; Zhou X; Guo Y; Jiang G; Yao C
J Ethnopharmacol; 2013 Dec; 150(3):907-17. PubMed ID: 24140602
[TBL] [Abstract][Full Text] [Related]
13. Increased Expression of IL-23 Receptor (IL-23R) in Vogt-Koyanagi-Harada (VKH) Disease.
Wang C; Wang L; Hu J; Li H; Kijlstra A; Yang P
Curr Eye Res; 2018 Nov; 43(11):1369-1373. PubMed ID: 29877734
[TBL] [Abstract][Full Text] [Related]
14. Elevated serum osteopontin levels and genetic polymorphisms of osteopontin are associated with Vogt-Koyanagi-Harada disease.
Chu M; Yang P; Hu R; Hou S; Li F; Chen Y; Kijlstra A
Invest Ophthalmol Vis Sci; 2011 Sep; 52(10):7084-9. PubMed ID: 21810982
[TBL] [Abstract][Full Text] [Related]
15. Cytokine production and helper T cell subsets in Vogt-Koyanagi-Harada's disease.
Imai Y; Sugita M; Nakamura S; Toriyama S; Ohno S
Curr Eye Res; 2001 Apr; 22(4):312-8. PubMed ID: 11462171
[TBL] [Abstract][Full Text] [Related]
16. Th1 and Th17 Predominance in the Enthesitis-related Arthritis Form of Juvenile Idiopathic Arthritis.
Mahendra A; Misra R; Aggarwal A
J Rheumatol; 2009 Aug; 36(8):1730-6. PubMed ID: 19531753
[TBL] [Abstract][Full Text] [Related]
17. [Expression of suppressor of cytokine signaling in peripheral blood monocular cells of patients with Vogt-Koyanagi-Harada disease].
Liu YX; Wang H; Peng XY; Zhou ZC
Zhonghua Yan Ke Za Zhi; 2009 Nov; 45(11):1015-9. PubMed ID: 20137421
[TBL] [Abstract][Full Text] [Related]
18. Dominance of activated T cells and interleukin-6 in aqueous humor in Vogt-Koyanagi-Harada disease.
Norose K; Yano A; Wang XC; Tokushima T; Umihira J; Seki A; Nohara M; Segawa K
Invest Ophthalmol Vis Sci; 1994 Jan; 35(1):33-9. PubMed ID: 8300361
[TBL] [Abstract][Full Text] [Related]
19. Activation of the liver X receptor inhibits Th17 and Th1 responses in Behcet's disease and Vogt-Koyanagi-Harada disease.
Wu L; Wen H; Zhou Y; Yu H; Liu Y; Bai L; Kijlstra A; Yang P
Curr Mol Med; 2014; 14(6):712-22. PubMed ID: 25056541
[TBL] [Abstract][Full Text] [Related]
20. Expression and role of interleukin-9 in Vogt-Koyanagi-Harada disease.
Peng Z; Jiang S; Wu M; Zhou X; Wang Q
Mol Vis; 2017; 23():538-547. PubMed ID: 28761327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
